The Cytoplasm Translocation of the Androgen Receptor Cofactor p44 as a Target for Prostate Cancer Treatment
Abstract
We determined the dosage reimen for adiministration of identified chemical compounds and found that identified compounds inhibited androgen-dependent growth of prostate tumors in nude mice. The growth inhibition is associated with suppression of p44 cytoplasm tranportation. We also found that the nuclear exclusion signal (NES1) of p44 does not function in the differentiated prostate epithelial cells. This finding reveals a novel mechanism by which p44 subcellular tranlocation is determined and regulated during prostate development and prostate tumorigenesis.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2013
- Accession Number
- ADA589529
Entities
People
- Zhengxin Wang
Organizations
- The University of Texas MD Anderson Cancer Center